Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06482164 · ClinicalTrials.gov registry record · NA
The THINK Study Incidence of Neurotrophic Keratopathy)
A NA study of Dry Eye, sponsored by Research Insight.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06482164 is a NA study of Dry Eye that is actively recruiting participants, run by Research Insight. The registered enrollment target is 60 participants, below the 94-participant average among 41 other Dry Eye trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06482164, a NA study of Dry Eye, is actively recruiting participants, sponsored by Research Insight.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The study purpose is to evaluate corneal sensitivity in patients that have Stage 1 Neurotrphic Keratopathy (NK). Identifying patients with Stage 1 NK, may predict those who will in the future require rhNGF for optimal visual performance.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Dry Eye Disease
Study Locations (1)
California
- Harvard Eye Associates - Laguna Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-04-05 |
| Est. Completion | 2025-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06482164
The ClinicalTrials.gov registry entry for NCT06482164 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 94-participant average among 41 other Dry Eye trials with a reported enrollment target (36% lower). The listed sponsor is Research Insight, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dry Eye appearing as the primary indexed condition, and to 1 intervention - of which Dry Eye Disease is the first listed.
NCT06482164 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06482164 about?
NCT06482164 is a clinical study titled "The THINK Study Incidence of Neurotrophic Keratopathy)". The study purpose is to evaluate corneal sensitivity in patients that have Stage 1 Neurotrphic Keratopathy (NK). Identifying patients with Stage 1 NK, may predict those who will in the future require rhNGF for optimal visual performance.
What is the current status of trial NCT06482164?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-04-05. Estimated completion is 2025-04-01.
What conditions does trial NCT06482164 study?
This clinical trial studies the following conditions: Dry Eye.
What interventions are being tested in trial NCT06482164?
The interventions under investigation include: Dry Eye Disease (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06482164?
This trial is sponsored by Research Insight, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06482164 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Low Level Light Therapy & Skin Pigmentation
RECRUITING · NA
-
Corneal Epithelial Stem Cells and Dry Eye Disease
COMPLETED · NA
-
Acute Comfort of Lubricant Eye Drops FID 112903
COMPLETED · NA
-
Evaluation of Extended Tear Film Break Up Time (TFBUT) With an Ocular Emulsion
COMPLETED · NA
-
Efficacy of IPL Treatment of Dry Eye and Ocular Rosacea
COMPLETED · NA
-
Intense Pulse Light Treatment With Meibomian Gland Expression of the Upper Eyelids in Dry Eye Disease
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.